The pending Bartlett case will determine whether Mensing applies to design-defect claims and whether it requires a finding that such claims against generic drug manufacturers are similarly preempted.

FORBES: DOJ/FDA Brief in SCOTUS Generic Drug Preemption Case Hands Plaintiffs New Liability Theories

In finding himself, he claims also to have found out the secret defect of modern Conservatism: that it came to be unloved because it became untender.

ECONOMIST: He who hesitates laughs last?